Corporate News
- Cell MedX Corp. to Attend The 29th Annual Wellness Show 2022 Held in Vancouver, BC March 24, 2022
- FDA Commences Review of Cell MedX’s Premarket Notification (510K) and Health Canada Renews Class II Medical Device Licenses for eBalance(R) Systems November 15, 2021
- Cell MedX Corp. Files Premarket Notification (510K) with the US Food and Drug Administration and Receives Canadian Trademark September 17, 2021
- Cell MedX Corp. Converts Debt to Shares, Closes Non-brokered Private Placement Financing, and Engages Investor Relations Consultants May 26, 2021
- Cell MedX Corp. Signs Extension Agreement with Think Ink Marketing September 24, 2020
- Cell MedX Corp.’s eBalance Pro System Receives Class II Medical Device License from Health Canada September 1, 2020
- Cell MedX Corp. (CMXC) Closes Non-Brokered Private Placement Financing August 4, 2020
- Cell MedX Corp.’s eBalance Home System Receives Class II Medical Device License from Health Canada July 22, 2020
- Cell MedX Corp. Files Two Applications for Class II Medical Device Licenses with Health Canada July 7, 2020
- Cell MedX Corp. Receives Quality Management System ISO 13485:2016 MDSAP Certificate June 9, 2020
Historical Press Releases
This website contains historical and archived press releases for Cell MedX Corp. The information in these press releases is historical in nature, has not been updated, and is current only to the date indicated in the particular press release. This information may no longer be accurate and therefore you should not rely on the information contained in these press releases. To the extent permitted by law, Cell MedX Corp and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.